{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T07:16:48Z","timestamp":1794727008641,"version":"4.9.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000096","name":"National Center on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1053\/j.gastro.2009.05.007","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T04:26:29Z","timestamp":1242275189000},"page":"549-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Weight-Related Effects on Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial"],"prefix":"10.1053","volume":"137","author":[{"given":"James E.","family":"Everhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae\u2013Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond T.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert L.","family":"Bonkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc G.","family":"Ghany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2009.05.007_bib1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cct.2004.08.003","article-title":"Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders","volume":"25","author":"Lee","year":"2004","journal-title":"Control Clin Trials"},{"key":"10.1053\/j.gastro.2009.05.007_bib2","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa0707615","article-title":"Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon","volume":"359","author":"Di Bisceglie","year":"2008","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1053\/j.gastro.2009.05.007_bib3","doi-asserted-by":"crossref","first-page":"S498","DOI":"10.1097\/00005768-200009001-00009","article-title":"Compendium of physical activities: an update of activity codes and MET intensities","volume":"32","author":"Ainsworth","year":"2000","journal-title":"Med Sci Sports Exerc"},{"key":"10.1053\/j.gastro.2009.05.007_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/archinte.1996.00440010113015","article-title":"Leisure-time physical activity among US adults","volume":"156","author":"Crespo","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2009.05.007_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1210\/jcem-44-4-681","article-title":"Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism","volume":"44","author":"Hayashi","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.gastro.2009.05.007_bib6","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2009.05.007_bib7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2009.05.007_bib8","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","article-title":"Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data","volume":"130","author":"Leandro","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2009.05.007_bib9","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1572-0241.2008.01813.x","article-title":"Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection","volume":"103","author":"Petta","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2009.05.007_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-8278(03)00479-3","article-title":"Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States","volume":"40","author":"Hu","year":"2004","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2009.05.007_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1463-1326.2003.00256.x","article-title":"The impact of diabetes and obesity on liver histology in patients with hepatitis C","volume":"5","author":"Friedenberg","year":"2003","journal-title":"Diabetes Obes Metab"},{"key":"10.1053\/j.gastro.2009.05.007_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/01.mcg.0000135372.10846.2a","article-title":"Obesity and nonalcoholic fatty liver disease in chronic hepatitis C","volume":"38","author":"Younossi","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2009.05.007_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0399-8320(04)94918-4","article-title":"Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients","volume":"28","author":"Cholet","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1053\/j.gastro.2009.05.007_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/jcp.2003.009357","article-title":"Steatosis and fibrosis in patients with chronic hepatitis C","volume":"57","author":"Wyatt","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.gastro.2009.05.007_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cgh.2006.11.002","article-title":"Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial","volume":"5","author":"Lok","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2009.05.007_bib16","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/gut.52.11.1638","article-title":"Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C","volume":"52","author":"Asselah","year":"2003","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2009.05.007_bib17","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/hep.21078","article-title":"Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection","volume":"43","author":"Perumalswami","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.05.007_bib18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.52.2.288","article-title":"Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies","volume":"52","author":"Castera","year":"2003","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2009.05.007_bib19","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/hep.22865","article-title":"Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis trial (HALT-C) trial","volume":"49","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.05.007_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/gast.2003.50004","article-title":"Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States","volume":"124","author":"Ruhl","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2009.05.007_bib21","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/dc06-0062","article-title":"Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999\u20132002","volume":"29","author":"Cowie","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2009.05.007_bib22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.amjmed.2007.03.025","article-title":"Impact of diabetes on the severity of liver disease","volume":"120","author":"Hickman","year":"2007","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2009.05.007_bib23","doi-asserted-by":"crossref","first-page":"E1709","DOI":"10.1152\/ajpendo.00444.2007","article-title":"Effect of liver fat on insulin clearance","volume":"293","author":"Kotronen","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"suppl","key":"10.1053\/j.gastro.2009.05.007_bib24","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508509007513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508509007513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:37:00Z","timestamp":1762162620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508509007513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0016508509007513"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2009.05.007","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weight-Related Effects on Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2009.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}